Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CNS Malignancy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT03426891
What this trial is testing

Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma

Who this might be right for
GlioblastomaBrain TumorGBM
H. Lee Moffitt Cancer Center and Research Institute 21
Early research (Phase 1)Study completedNCT00068510
What this trial is testing

Vaccine Therapy in Treating Patients With Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 28
Not applicableLooking for participantsNCT07657403
What this trial is testing

CONNEctome-guided Navigation for Eloquent-area Tumor Surgery Trial

Who this might be right for
Brain NeoplasmsEloquent Area Brain Tumors
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 200
Early research (Phase 1)Study completedNCT00002572
What this trial is testing

Cytotoxic T Cells and Interleukin-2 in Treating Adult Patients With Recurrent Brain Tumors

Who this might be right for
Brain and Central Nervous System Tumors
University of Colorado, Denver 10
Not applicableUnknownNCT04489992
What this trial is testing

Experiment on the Use of Innovative Computer Vision Technologies for Analysis of Medical Images in the Moscow Healthcare System

Who this might be right for
AI (Artificial Intelligence)Mammary CancerLung Cancer+6 more
Research and Practical Clinical Center for Diagnostics and Telemedicine Technologies of the Moscow Health Care Department 133,000
Testing effectiveness (Phase 2)Temporarily pausedNCT06639607
What this trial is testing

PEP-CMV + Nivolumab for Newly Diagnosed Diffuse Midline Glioma/High-grade Glioma and Recurrent Diffuse Midline Glioma/High-grade Glioma, Medulloblastoma, and Ependymoma

Who this might be right for
Diffuse Midline GliomaDiffuse Midline High-grade GliomaMedulloblastoma+1 more
Washington University School of Medicine 68
Early research (Phase 1)Study completedNCT00509431
What this trial is testing

Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
Jonsson Comprehensive Cancer Center 19
Early research (Phase 1)Study completedNCT00646139
What this trial is testing

KX2-391 in Treating Patients With Advanced Solid Tumors or Lymphoma That Did Not Respond to Treatment

Who this might be right for
LymphomaLymphoproliferative DisorderSmall Intestine Cancer+1 more
Roswell Park Cancer Institute 7
Early research (Phase 1)Ended earlyNCT00826930
What this trial is testing

Trans Sodium Crocetinate (TSC) Study of Intra-tumoral Oxygen Concentration, Safety, and Pharmacokinetics in Patients With High Grade Glioma

Who this might be right for
High Grade Glioma
Diffusion Pharmaceuticals Inc 1
Early research (Phase 1)Study completedNCT02859207
What this trial is testing

Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects

Who this might be right for
Early Alzheimer's Disease
Eisai Inc. 32
Testing effectiveness (Phase 2)Looking for participantsNCT06607692
What this trial is testing

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

Who this might be right for
Solid Tumor CancerMedulloblastomaHigh Risk Neuroblastoma+19 more
Fundación de investigación HM 25
Early research (Phase 1)Looking for participantsNCT04842812
What this trial is testing

Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors

Who this might be right for
Liver CancerLung CancerBreast Cancer+5 more
Second Affiliated Hospital of Guangzhou Medical University 40
Early research (Phase 1)Ended earlyNCT02244112
What this trial is testing

Oprozomib to Assess Food Effect, Drug-Drug Interaction With Midazolam, and Safety and Tolerability in Patients With Advanced Malignancies

Who this might be right for
Advanced Non-Central Nervous System (CNS) Malignancies
Amgen 43
Not applicableUnknownNCT00278239
What this trial is testing

Quality of Life in Patients Who Have Undergone Previous Treatment for Primitive Neuroectodermal Tumors

Who this might be right for
Brain and Central Nervous System TumorsCognitive/Functional EffectsLong-term Effects Secondary to Cancer Therapy in Children+1 more
Children's Cancer and Leukaemia Group
Testing effectiveness (Phase 2)Study completedNCT02537600
What this trial is testing

Vemurafenib and Cobimetinib Combination in BRAF Mutated Melanoma With Brain Metastasis

Who this might be right for
Malignant Melanoma
Center Eugene Marquis 43
Not applicableStudy completedNCT03666507
What this trial is testing

Vegetative Monitoring During Brainstem-associated Surgery

Who this might be right for
Brain Tumor, RecurrentVestibular SchwannomaBrainstem Neoplasm+1 more
University Hospital Tuebingen 103
Very early researchEnded earlyNCT02279992
What this trial is testing

Pilot Study of Vardenafil and Carboplatin in Patients With Gliomas and Brain Metastases

Who this might be right for
GliomaBrain NeoplasmsBrain Metastasis
Cedars-Sinai Medical Center 7
Not applicableUnknownNCT04671368
What this trial is testing

Diagnostic Efficiency of Artificial Intelligence for Surgical Neuropathology

Who this might be right for
Central Nervous System Neoplasms
Jinsong Wu 141
Not applicableEnded earlyNCT03403361
What this trial is testing

Dual-Energy CT on Plan Quality, Dose-delivery Accuracy, and Simulated Outcomes of Patients Treated With Proton or Photon Therapy

Who this might be right for
Lung CancerBrain CancerHead and Neck Cancer
Washington University School of Medicine 36
Early research (Phase 1)Study completedNCT00730613
What this trial is testing

Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma

Who this might be right for
Brain and Central Nervous System Tumors
City of Hope Medical Center 3
Next Page